EXCLUSIVE LICENSE AGREEMENT PREAMBLEExclusive License Agreement • December 18th, 2020 • Sana Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 18th, 2020 Company Industry JurisdictionThis agreement (“Agreement”) is made and entered into, effective as of the date of last signature below, (“Effective Date”) by and between: Washington University, a corporation established by special act of the Missouri General Assembly approved February 22, 1853 and acts amendatory thereto, having its principal offices at One Brookings Drive, St. Louis, Missouri 63130 (hereinafter referred to as “WU”); and Sana Biotechnology, Inc. a corporation organized and existing under the laws of the State of Delaware, having its principal offices at 188 E Blaine Street, Suite 400, Seattle, WA 98102 (hereinafter referred to as “Licensee”) and the following correspondence addresses, each a “Party” or collectively the “Parties” of this Agreement:
EXCLUSIVE LICENSE AGREEMENT PREAMBLEExclusive License Agreement • December 18th, 2020 • Sana Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 18th, 2020 Company Industry JurisdictionThis agreement (“Agreement”) is made and entered into, effective as of the date of last signature below, (“Effective Date”) by and between: Washington University, a corporation established by special act of the Missouri General Assembly approved February 22, 1853 and acts amendatory thereto, having its principal offices at One Brookings Drive, St. Louis, Missouri 63130 (hereinafter referred to as “WU”); and Sana Biotechnology, Inc. a corporation organized and existing under the laws of the State of Delaware, having its principal offices at 188 East Blaine Street, Suite 400, Seattle, WA 98102 (hereinafter referred to as “Licensee”) and the following correspondence addresses, each a “Party” or collectively the “Parties” of this Agreement: